Regulation of ferroptosis-related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer

© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd..

BACKGROUND: Drug resistance has led to the failure of immunotherapy in triple negative breast cancer patients. Here we aimed to explore the mechanisms of drug resistance in patients in order to enhance their response to immunotherapy.

METHODS: We downloaded publicly available single-cell RNA-sequencing data of peripheral blood mononuclear cells from patients after treatment to investigate the possible mechanisms of drug resistance. The publicly available TCGA transcriptomic data and somatic mutation data were used for further validation. In this study, a series of bioinformatics and machine learning methods were employed.

RESULTS: We identified the vital roles of CD8+ NKT cells and classical monocytes in the immunotherapy response of triple-negative breast cancer patients. The proportion of these cell types was significantly increased in group partial response. We also found that downregulation of ferroptosis-related genes regulates the immune pathway. The analysis of scRNA data and TCGA transcriptomic data presented that DUSP1 may play a crucial role in immunotherapy resistance.

CONCLUSION: Overall, the composition of the tumor microenvironment affects the immunotherapy response of patients, and DUSP1 may be a potential target for overcoming drug resistance.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Thoracic cancer - 14(2023), 34 vom: 31. Dez., Seite 3369-3380

Sprache:

Englisch

Beteiligte Personen:

Liu, Zheming [VerfasserIn]
He, Songjiang [VerfasserIn]
Huang, Zhou [VerfasserIn]
Liu, Jiahui [VerfasserIn]
Gong, Yiping [VerfasserIn]
Yao, Yi [VerfasserIn]
Zhang, Xue [VerfasserIn]

Links:

Volltext

Themen:

Drug resistance
Ferroptosis
Immunotherapy
Journal Article
Triple-negative breast cancer
Tumor microenvironment

Anmerkungen:

Date Completed 05.12.2023

Date Revised 05.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/1759-7714.15128

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36323361X